Le Lézard
Classified in: Health
Subjects: PDT, MAT

SprinJene® CBD Toothpaste Hits Shelves in United States


PISCATAWAY, N.J., Dec. 2, 2020 /PRNewswire/ -- SprinJene®, a leader in natural oral care products, announces the launch of its CBD Toothpaste, available for online sale as of Monday, December 7, 2020. The product is the first of several scientifically formulated, hemp-derived, oral care products containing cannabinoids -- including broad-spectrum CBD -- that will be created and launched under the SprinJene® brand in a partnership announced earlier this year.

 

Research shows that cannabinoids will play a major role in the future of oral care, and Zelira was the perfect partner.

SprinJene® CBD Toothpaste is a proprietary toothpaste formulation developed by SprinJene® CEO and Founder Dr. Sayed Ibrahim and Zelira Therapeutics, a global therapeutic medical cannabis company focused on developing branded cannabis products for the treatment of a variety of medical conditions such as insomnia, autism and chronic non-cancer pain.

Research shows that incorporating CBD into oral/dental care results in health benefits such as: naturally eliminating decay-causing bacteria, reducing gum inflammation, restoring pH balance and increasing remineralization, reducing bone loss associated with gum disease, and helping to improve overall health. Unlike other national brands that use hemp seed oil -- which does not contain CBD -- SprinJene® CBD Toothpaste uses broad-spectrum, THC-free CBD distillate derived from hemp. This key difference provides SprinJene® users with the full benefits of a wide array of cannabinoids, with no  psychoactive effects.

"The SprinJene brand is built on harnessing the power of natural ingredients to protect and improve our oral health, and CBD, with its inherent anti-inflammatory, antibacterial and homeostatic properties are shown to be powerful tools in that fight," says Dr. Sayed Ibrahim, CEO of SprinJene. "Research is showing that cannabinoids will be a major part of the future of oral care, and Zelira was the perfect partner for Sprinjene to set the industry standard in broad spectrum, hemp-derived oral care formulations."

"SprinJene® was an early adopter of nature-based oral care, and they are continuing to innovate now by recognizing the effectiveness of CBD and other cannabinoids  in improving our head-to-toe health," says Dr. Oludare Odumosu, Zelira's CEO & Managing Director (USA).  "Zelira is thrilled to enter the national oral care market alongside a company that values the harmony of nature and science as much as we do."

About SprinJene®

SprinJene® is a socially conscious brand dedicated to marrying the benefits of science and nature in the creation of gluten-free, cruelty-free, vegan, Kosher, USDA Bio-preferred and Halal oral care products that are void of harsh chemicals and abrasives. All SprinJene® products are manufactured by Health and Natural Beauty USA Corp., a New Jersey based GMP contract manufacturing company. SprinJene's mission is to deliver the most advanced, safe, gentle and natural oral care options for brushers of all lifestyles. The company firmly believes that oral health is the gateway to internal health; that's why every SprinJene toothpaste features its patented formula of cold pressed black seed oil and zinc. There are currently two oral care product lines under the SprinJene umbrella: SprinJene Original® and SprinJene Natural®. SprinJene continues to source the globe for advanced, healthy ingredients to include in their products in order to improve the oral wellness of brushers everywhere. The staff at SprinJene® are dedicated to continually advancing their cGMP processes, products and certifications to provide the best oral care products. SprinJene® is available nationwide at retailers including Bed Bath & Beyond, Amazon, Central Market, Sprouts, Lassen's, Haggens, and VitaCost and can be found around the globe in France, Russia, UK, Singapore, Ukraine, China, Morocco, United Arab Emirates, Saudi Arabia, and Sudan. For more information, visit sprinjene.com.

SOURCE Zelira Therapeutics Limited


These press releases may also interest you

at 22:00
The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects for the development of new drugs for malaria and neglected tropical diseases (NTDs).2  The...

at 21:00
Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced today that it has focused its development and commercialization efforts for its RT-100 and RT-200 gene...

at 20:05
Organovo Holdings, Inc. ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D) human tissues, today announced the...

at 20:00
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology...

at 19:30
NCPDP announced today highlights from its 2024 Annual Technology & Business Conference, Innovation Starts Here. "NCPDP's standards and guidance are inherently innovative, and the work we continue to do will expand interoperability to support the...

at 19:25
Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company's breakthrough RESILIA tissue technology, designed to extend the valve's durability.*...



News published on and distributed by: